Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance

Impaired angiogenesis and tumor development by inhibition of the mitotic kinesin Eg5

(2015) Prisca Exertier et al.   Oncotarget

Taxanes in cancer of the head and neck

(2014) Krzysztof Misiukiewicz et al.   ANTI-CANCER DRUGS

Recent progress with microtubule stabilizers: new compounds, binding modes and cellular activities

(2014) Cristina C. Rohena et al.   NATURAL PRODUCT REPORTS

Spatial organization of cytokinesis signaling reconstituted in a cell-free system

(2014) P. A. Nguyen et al.   SCIENCE

Cdk1 Coordinates Timely Activation of MKlp2 Kinesin with Relocation of the Chromosome Passenger Complex for Cytokinesis

(2014) Mayumi Kitagawa et al.   Cell Reports

SIRT6 modulates paclitaxel and epirubicin resistance and survival in breast cancer

(2013) Mattaka Khongkow et al.   CARCINOGENESIS

FOXM1 targets NBS1 to regulate DNA damage-induced senescence and epirubicin resistance

(2013) P Khongkow et al.   ONCOGENE

SUMOylation inhibits FOXM1 activity and delays mitotic transition

(2013) S S Myatt et al.   ONCOGENE

MKlp2 inhibitior paprotrain affects polar body extrusion during mouse oocyte maturation

(2013) Jun Liu et al.   Reproductive Biology and Endocrinology

Immunological responses to a multi-peptide vaccine targeting cancer-testis antigens and VEGFRs in advanced pancreatic cancer patients

(2013) Ryuji Okuyama et al.   OncoImmunology

ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia

(2012) S. G. Landt et al.   GENOME RESEARCH

The Forkhead Box M1 protein regulates BRIP1 expression and DNA damage repair in epirubicin treatment

(2012) L J Monteiro et al.   ONCOGENE

Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012

(2011) L Galluzzi et al.   CELL DEATH AND DIFFERENTIATION

Mitotic catastrophe: a mechanism for avoiding genomic instability

(2011) Ilio Vitale et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

FOXO3a represses VEGF expression through FOXM1-dependent and -independent mechanisms in breast cancer

(2011) C T Karadedou et al.   ONCOGENE

Relocation of Aurora B and Survivin from Centromeres to the Central Spindle Impaired by a Kinesin-Specific MKLP-2 Inhibitor

(2010) Sergey Tcherniuk et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

FOXM1 Confers Acquired Cisplatin Resistance in Breast Cancer Cells

(2010) J. M.-M. Kwok et al.   MOLECULAR CANCER RESEARCH

Constitutively Nuclear FOXO3a Localization Predicts Poor Survival and Promotes Akt Phosphorylation in Breast Cancer

(2010) Jie Chen et al.   PLoS One

An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients

(2009) Balazs Györffy et al.   BREAST CANCER RESEARCH AND TREATMENT

Traffic control: regulation of kinesin motors

(2009) Kristen J. Verhey et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Kinesin superfamily motor proteins and intracellular transport

(2009) Nobutaka Hirokawa et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer

(2008) Helen M. Coley   CANCER TREATMENT REVIEWS

Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression

(2008) J. M-M. Kwok et al.   MOLECULAR CANCER THERAPEUTICS

Emerging Agents in the Treatment of Anthracycline- and Taxane-Refractory Metastatic Breast Cancer

(2008) Windy Dean-Colomb et al.   SEMINARS IN ONCOLOGY